| Followers | 19 |
| Posts | 6566 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Saturday, March 07, 2026 8:47:24 PM
WQLF SAYS: This is why CV SCIENCES discontinued CV Acute and CV Defense Products. YQUR dis- information is so EASY to Debunk. The WQLF dislikes Dishonest People YQU Now Understand YQU Understand. Have MERCY WQLF ahoooooo
Ai Generated :
Based on the search results, CV Sciences discontinued or phased out their CV Acute and CV Defense products as part of a strategic shift in their product portfolio and, in some cases, due to the products selling out and being replaced by newer, non-cannabinoid, and CBD-based offerings.
Here are the key factors contributing to this change:
Product Line Evolution: CV Sciences shifted focus towards new product lines. In 2024, they launched +PlusHLTH, a new line of cannabinoid-free supplements (including products named Clarity, Peace, and ReShape) and expanded their +PlusCBD pet products.
Strategic Shift to +PlusHLTH: The company moved towards targeting specific wellness needs (focus, mood, energy) with new formulations rather than focusing on the initial immunity-focused products.
"Sold Out" Status: The CV Defense product, in particular, was listed as "sold out" on their own website and in other channels, indicating a cessation of production or replacement.
Market Trends: While initially launched in 2020 to address immune needs during the pandemic and gain access to channels like Amazon (which restricted CBD at the time), the company ultimately shifted its focus to a broader, more diverse portfolio of consumer wellness products.
The company continues to focus on its flagship +PlusCBD brand, which remains a top-selling product line, according to their financial reports.
Wolfman Jack Said: Have Mercy on your soul. ahoooooo
https://share.google/fhmsmQY3gYxyBL6F8
Ai Generated :
Based on the search results, CV Sciences discontinued or phased out their CV Acute and CV Defense products as part of a strategic shift in their product portfolio and, in some cases, due to the products selling out and being replaced by newer, non-cannabinoid, and CBD-based offerings.
Here are the key factors contributing to this change:
Product Line Evolution: CV Sciences shifted focus towards new product lines. In 2024, they launched +PlusHLTH, a new line of cannabinoid-free supplements (including products named Clarity, Peace, and ReShape) and expanded their +PlusCBD pet products.
Strategic Shift to +PlusHLTH: The company moved towards targeting specific wellness needs (focus, mood, energy) with new formulations rather than focusing on the initial immunity-focused products.
"Sold Out" Status: The CV Defense product, in particular, was listed as "sold out" on their own website and in other channels, indicating a cessation of production or replacement.
Market Trends: While initially launched in 2020 to address immune needs during the pandemic and gain access to channels like Amazon (which restricted CBD at the time), the company ultimately shifted its focus to a broader, more diverse portfolio of consumer wellness products.
The company continues to focus on its flagship +PlusCBD brand, which remains a top-selling product line, according to their financial reports.
Wolfman Jack Said: Have Mercy on your soul. ahoooooo
https://share.google/fhmsmQY3gYxyBL6F8
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
